NeuroDiscovery AI offers a specialised AI platform for neurology that helps doctors diagnose brain diseases and ...

Lumonus, a leader in AI powered radiation oncology workflow solutions, today announced the close of its A$25 million Series B financing round. The round was led by Aviron Investment Management with ...

COPENHAGEN, Denmark, November 6, 2025 - Evaxion A/S (NASDAQ: EVAX) ('Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, provides business update ...

The healthcare industry is buzzing with the transformative potential of artificial intelligence (AI) and machine learning (ML). However, amid the hype, a major sticking point is often overlooked: the ...

Chicago-based Rush University Medical Center has added 1,705 more surgeries and reclaimed more than 257,000 case minutes between fiscal years 2021 and 2024 — a gain driven by predictive analytics ...

Is the health care system financially sustainable? When the HFMA asked industry experts, the answer was a resounding "no." ...

Company announces U.S. FDA clearance of Investigational New Drug (IND) application for STRO-004, its potential best-in-class Tissue Factor ADC; Expects to dose first patient before year-end - ...

In the era of artificial intelligence, the rapid advancements in AI and robotics are revolutionizing healthcare — reshaping ...

Keep reading to learn more about Synchron, Lumonus AI, Hullbot, Cytophenix, Nbryo, Giftbee, Understanding Zoe, and Zeligate.

Full-year 2025 guidance -- Revenue expected between $365 million-$375 million, non-GAAP gross margins of 78%-80%, non-GAAP ...

Received CTA authorization for Phase 1 trial of lead program AX-0810, targeting NTCP for cholestatic diseasesInitiating Phase 1 study of AX-0810 in healthy volunteers, with initial safety, tolerabilit ...

Although rare kidney diseases remain a significantly overlooked contributor to the global burden of CKD, things have begun to ...